8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
1/19
?
Vg~o` Kcj`jkoc Voxbyoz{ hocoa ag`hwlw`i Gej{jg`{j Vganjozoo`
ho` Geglxjejxo{ Vgcozo`o` hj ^waob [oljx+
H~. Hmhz Ej~ao`ho# [v.O# AO
Lgxwo Lmajxg Aghjl
^[WV Eoxaoyoxj# Dolo~xo.
Vg`hobwcwo`
Hocoa agcolwlo` guocwo{j lgnjdolo` ho` {j{xga cozo`o` lg{gboxo`
"bgocxbko~g {z{xga o`h vmcjkjg{ guocwoxjm`* oho ; l~jxg~jo lw`kj zol`j
l~jxg~jo geglxjejxo{# gej{jg`{j# ho` lgng~ohjco`-glwjxj "geegkxjug`g{{#geejkjg`kz o`h gqwjxz*? zo`i ag~wvolo` {woxw ~o`ilojo` {j{xgaoxjl hocoa
{woxw {j{xga. Agcolwlo` {woxw o`ocj{j{ glm`maj hocoa vgcozo`o` lghmlxg~o`
v~meg{j ohocob xjhol awhob# ag`ij`iox no`zol eolxm~ zo`i bo~w{
hjvg~xjano`ilo` ho~j ng~noioj hjag`{j xg~ao{wl ko~o vg`hgloxo` ho~j dg`j{
o`ocj{j{ glm`maj zo`i olo` hjiw`olo`# noxo{o` xg~aj`mcmij glm`maj jxw {g`hj~j
ag`ig`oj wxjcjtoxjm # v~mhwkxjujxz# ng`gejx# geejkjg`kz# geegkxjug`g{{# uocwg
em~ am`gz# lgnjdolo` ej{loc ho` xj`ilox j`ecoxjm` ~oxg zo`i {g~j i locj
ng~wnob. Hj{oavj`i lgxg~noxo{o` {wang~ hozo ho` lgnjdolo` glm`maj zo`i
hjvg`io~wbj vmcjxj{# {gbj`iio xjhol do~o`i )~g{mw~kg{) xg~{gnwx xgcob hjvoiwag`dohj )ejrgh).>
[gho`ilo` hj {j{j hjag`{j coj` v~meg{j jxw {g`hj~j hjxw`xwx w`xwl ag`j iloxlo`
awxw vgcozo`o``zo ho` lgv~meg{jo``zo hocoa lm~jhm~ gxjl!{m{jm!nwhozo {g~xo
ng~noioj vg~oxw~o` ho` vg~w`ho`io` bwlwa.>
+ Hj{oavojlo` voho oko~o Vg~xgawo` Guocwo{j Dgdo~j`i Vg`o`iiwco`io` Ao{ocob Lg{gboxo` Ao{zo~olox hjDoyo Xjaw~ hj{gcg`iio~olo` mcgb Hj`o{ Lg{gboxo` V~muj`{j Doyo Xjaw~ hj Bmxgc Wxoaj [jhmo~dm [w~onozo#
>? !>> @mugang~ >6??.? Ohoz CO# Ngicgz KG# Coj~{m` H^. Guocwoxj`i xbg bgocxbko~g {z{xga4 geegkxjug`g{{# geejkjg`kz o`h gqwjxz.
;~h gh. Yo{bj`ixm` HK4 Bgocxb Ohaj`j{x~oxjm` V~g{{# >668.> Ej~ao`ho H. Ovcjlo{j j`xgi~o{j {j`g~ij{ o`xo~o Gujhg`ug!no{gh Aghjkj`g# Gujhg`kg!no{gh Bgocxbko~g ho`
Gujhg`kg!no{gh Vmcjkz hocoa {oxw {j{xga vg`j`iloxo` awxw vgcozo`o` lg{gboxo` ho` lghmlxg~o`
"Kcj`jkoc Imug~`o`kg*4 {woxw xo`xo`io` v~meg{j JHOJ hj ao{o ag`hoxo`i.JJ.Km{x Geegkxjug`g{{ O`ocz{g{
"KGO* [xo`ho~ Vgcozo`o` Aghj{ "[VA* Lg{gboxo` O`ol JHOJ Hj{oavojlo` voho Oko~o Vg~xgawo`
Vg~bjavw`o` M~io`j{o{j V~meg{j hg`io` Hjxdg` Zo` Aghjl Hgvlg{ ^J hj Nmim~ [gvxgang~ >667.
bxxv4--yyy.{k~jnh.kma-hmk-?>2>9:;5-Hmhz!Ej~ao`ho!>667!68>!Ovcjlo{j!j`xgi~o{j!{j`g~ij{!
Gujhg`ugno{gh!Aghjkj`g!Gujhg`kgno{gh!Bgocxbko~g!ho`!Gujhg`kgno{gh!Vmcjkz!hocoa!Kcj`jkoc!Imug
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
2/19
>
[gho`ilo` j{xjcob# hgej j{j ho` hjag`{j olo` gej{jg`{j dwio ngcwa oho
lg{gvoloxo` zo`i dgco{ ho` gl{vcj{jx xg~io`xw`i ho~j ng~noioj vg~{vglxje.
Gej{jg`{j hovox hjimcm`ilo` lgvoho gej{jg`{j xgb`jl "xgkb`jkoc geejkjg`kz*#gej{jg`{j v~mhwl{j-bo{jc "v~mhwkxjug geejkjg`kz* ho` gej{jg`{j ocmloxje
"occmkoxjug-{mkjgxoc geejkjg`kz* xg~ao{wl hjhocoa`zo njho`i ao~lgx ho`
lg{gboxo`.?#; "Xongc ?*
Xongc ?. Ng~noioj hgej`j{j hoa hjag`{j xj`ilox o`ocj{j{ xg`xo`i geglxjejxo{#
gejg`{j ho` lgng~ohjco`-glwjxj.?
; Ej~ao`ho H. Vg`ig`hocjo` awxw ho` gej{jg`{j vganjozoo` cozo o` lg{gboxo`. Hj{oavojlo` hocoa ~o`ilo
guocwo{j V~mi~oa Vgcozo`o` O{lg{ Xg~vohw ^waob [oljx "VVOX^[* hj{gcg`iio~olo` mcgb Lo`xm~ Vw{ox
VX O{lg{ "Vg~{g~m* hj Bmxgc Vo`m~oao Noxoa ?6 Hg{gang~ >662.
bxxv4--yyy.{k~jnh.kma-hmk-:266292-Hmhz!Ej~ao`ho!>662!Vg`ig`hocjo`!Awxw!Ho`!Gej{jg`{j!Njozo!^[!
?6!Hg{gang~!>662
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
3/19
;
Gumcw{j {j{xga cozo`o` lg{gboxo` hj {o~o`o lg{gboxo` "~waob {oljx* {gko~o
v~j {jv`zo awcoj ho~j zo`i ng~kj~jlo` hmj`i xbj`i{ kbgovg~ hocoa boc j`j
geejkjg`kz voho xobw` ?:96o` voho yolxw l~j{j{ lgwo`io` ho` igdmcol MVGK#lgawhjo` glm`maj awcoj vwcjb ho` ao{zo~olox ag`w`xwx cozo`o` lg{gboxo`
ng~kj~jlo` hmj`i xbj`i{ ngxxg~hocoa boc j`j qwocjxz jav~mugag`x. [gcoao hwo
hglohg xg~{gnwx ao`odgag` ng~km~ol hmj`i xbj`i{ ~jibx "hjlg`oc {gnoioj
j`k~go{j`i geegkxjug`g{{* zo`i ag~wvolo` lmanj o{j hmj`i xbj`i{ kbgovg~ho` hmj`i xbj`i{ ngxxg~. Xg~`zoxo v~j`{jv hmj i xbj`i{ ~jibxxjhol agaohoj
ag`ijlwxj vg~lgano`io` lgaodwo` xgl`mcmij aowvw` xw`xwxo` ao{zo~olox
zo`i {gaolj` l~jxj{< ho` v~j`{jv ao`odgag` hmj`i xbj`i{ ~jibxxg~{gnwx xgcob
lgxj`iioco` toao` ho` hjo`iiov {gnoioj v~j`{jv ho` ko~o ao`odgag` lw`m.
Voho onoh >? j`j ao{o g~o icmnocj{o{j hjnwxwblo` xjhol bo`zo hmj`i xbj`i{~jibx# olo` xgxovj dwio hjvg~cwlo` v~j`{jv ao`odgag` hmj`i xbg ~jibx xbj`i{
{gbj`iio lmanj`o{j lghwo`zo hj{gnwx {gnoioj v~j {jv ao`odgag` cozo`o`
amhg~` hmj`i xbg ~jibx xbj`i{ ~jibx. 8
Co`ho{o` Bwlwa
Hocoa W`ho`i W`ho`i ^J @mam~ >: Xobw` >668 xg`xo`i V~olxjl Lghmlxg~o`
voho vo{oc 87 ag`g~o`ilo` xg`xo`i lgyodjno` ag`zgcg`iio~olo` lg`hocjawxw ho` lg`hocj njozo.7 Voho W`ho`i W`ho`i ^J @mam~ 88 Xobw` >6?6
xg`xo`i ^waob [oljx voho vo{oc ;; ag`g~o`ilo` xg`xo`i m~io`j{o{j
~waob {oljx zo`i geglxje# gej{jg`# ho` olw`xongc. 5 Vg~oxw~o` Vgag~j`xob
@mam~ >; Xobw` >667 xg`xo`i Vg`igcmcoo` Lgwo`io` Noho` Cozo`o` Wawa
ho` Vg~oxw~o` Ag`xg~j Hocoa @gig~j @mam~ 5? Xobw` >669 xg`xo`i
Vghmao` Xgl`j{ Vg`igcmcoo` Lgwo`io` Noho` Cozo`o` Wawa Hog~ob voho
vo{oc ? ozox ? ag`zgnwxlo` w`xwl agang~jlo` vgcozo`o` lgvoho ao{zo~olox
ng~wvo vg`zghjoo` no~o`i ho`-oxow do{o zo`i hjdwoc xo`vo ag`iwxoaolo`
ag`ko~j lgw`xw`io` ho` hocoa agcolwlo` lgijoxo``zo hjho{o~lo` voho
v~j`{jv gej{jg`{j ho` v~mhwlxjujxo{.9#2
8 Ej~ao`ho H. Vg~o` Geglxjejxo{ Lcj`j{ hocoa ~o`ilo agywdwhlo` lg{gcoaoxo`-lgoao`o` "{oegxz* ho`
ng~m~jg`xo{j lgvoho vo{jg` "voxjg`x kg`x~gh`g{{*.Hj{oavojlo` voho Bm{vjxoc Ao`oigag`x ; zo`ihj{gcg`iio~olo` mcgb Vw{ox Lodjo` Ohaj`j{x~o{j ho` Lgnjdolo` Lg{gboxo` ELA WJ hj I~o`h O`ilo{o
Bmxgc J`xg~`oxjm`oc# Agho` ?? Oiw{xw{ >662. bxxv4--yyy.{k~jnh.kma-hmk-:2?;???-Hmhz!Ej~ao`ho!>662!
Vg~o`!Geglxjujxo{!Lcj`j{!Hocoa!VOXB7 W`ho`i W`ho`i ^J @mam~ >: Xobw` >668 xg`xo`i V~olxjl Lghmlxg~o`5 W`ho`i W`ho`i ^J @mam~ 88 Xobw` >6?6 xg`xo`i ^waob [oljx9 Vg~oxw~o` Vgag~j`xob ^J @mam~ >; Xobw` >667 xg`xo`i Vg`igcmcoo` Lgwo`io` Noho` Cozo`o` Wawa2 Vg~oxw~o` Ag`xg~j Hocoa @gig~j @mam~ 5? Xobw` >669 xg`xo`i Vghmao` Xgl j{ Vg`igcmcoo` Lgwo`io`
Noho` Cozo`o` Wawa Hog~ob
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
4/19
8
Kcj`jkoc Voxbyoz{ hocoa Gej{jg`{j Vganjozoo`# Geglxjejxo{ Vgcozo`o` ho`
Lgng~ohjco`-Glwjxj
Kcj`jkoc Voxbyoz{ "KV* ohocob {woxw lm`{gv vg~g`ko`oo` vgcozo`o` xg~vohwzo`i ag~o`ilwa {gxjov co`ilob zo`i hjng~jlo` lgvoho vo{jg` ng~ho{o~lo`
{xo`ho~ vgcozo`o` aghj{ ho` o{wbo` lgvg~oyoxo` zo`i ng~no{j{ nwlxj hg`io`
bo{jc zo`i xg~wlw~ ho` hocoa do`ilo yolxw xg~xg`xw {gcoao hj ~waob
{oljx.:#?6#??
Ng~jlwx bo{jc vg`gcjxjo` vg`g~ovo` Kcj`jkoc Voxbyoz{ V`gwam`jo "Ioano~ ?
ho` >* zo`i hjcolwlo` hocoa ~o`ilo aganwlxjlo` oho`zo gej{jg`{j njozo#
geglxjejxo{ cozo`o` ho` lgng~ohjco`-glwjxj noij {gawo vo{jg` xo`voagao`ho`i coxo~ ngcolo`i lgohoo` {m{joc glm`maj# vg`hjhjlo` aowvw`
ig`hg~. Ho~j Ioano~ ? ho` > hj noyob w`xwl lo{w{ v`gwam jo njozo
vg~oyoxo` {oavoj {ganwb "hg`io` xo~je ~waob {oljx* agavg~iw`olo` Kcj`jkocVoxbyoz{ V`gwam`jo ohocob {gljxo~ ^v 8:7 666#! w`xwl lgco{ JJJ# ^v ? ?>6
666#! w`xwl lgco{ JJ# ^v ? 826 666#! w`xwl lgco{ J ho` ^v > ?76 666#! w`xwl
lgco{ UJV. [gho`ilo` njco hjbjxw`i ng~ho{o~lo` lcoja Doalg{ao{ w`xwl lo{w{
zo`i {oao ohocob ^v > 969 55;#!. Aolo {gko~o aoxgaoxjl hg`io`
agavg~iw`olo` Kcj jkoc Voxbyoz{ w`xwl lo{w{ v`gwam`jo xg~{gnwx
ag`ibgaox "> 969 55; 8:7 666 1 ^v > >?> 55;#!*. Hg`io` hgajljo`xg~cjbox dgco{ ho~j {gij glm`maj-vganjozoo` ~waob {oljx xg~{gnwx {o`iox
gej{jg` ho` ag`iw`xw`ilo` njco ag`iiw`olo` Kcj`jkoc Voxbyoz{.
Hg`io` agavg~iw`olo` Kcj`jkoc Voxbyoz{ hovox ag`ibjxw`i Km{x Ygjibx
{gxjov lgcmavml lo{w{# km`xmb w`xwl lo{w{ v`gwam`jo hj oxo{ ~g~oxo
{wang~hozo "~g{mw~kg{* ~waob {oljx "mnox mnoxo`# nobo` ho` ocox hcc* zo`ixg~voloj ohocob ^v >76 666#! aolo Km{x!Ygjibx `zo ohocob "876 666->76
666 1 ?.2*.
: Ej~ao`ho H. Vghmao` Vg`zw{w`o` Kcj`jkoc Voxbyoz{ hocoa ~o`ilo javcgag`xo{j [j{xga H^I{ Ko{gajr
hj ~waob {oljx. Hj{oavojlo` hocoa [jho`i Vcg`m Lmajxg Aghjl ^[ Eoxaoyoxj# Dolo~xo 9 Mlxmng~
>667.?6 Ej~ao`ho H. Kcj`jkoc Voxbyoz{4 Vg~o` v~meg{j aghj{ hocoa ~o`ilo ag`zw{w` [j{xga H^I{ Ko{gajr hj
~waob {oljx. Hj{oavolo` voho lw`dw io` covo`io` lg ^[WV Ohoa Aocjl Agho` >> Hg{gang~ >667#
^[WV Bo{o` [ohjlj` No`hw`i >; Hg{gang~ >667 ho` Guocwo{j Vg`zw{w`o` Kcj`jkoc Voxbyoz{ hocoa
~o`ilo vg`zgavw~`oo` Vghmao` H^I{ Ko{gajr Hgvlg{ ^J# Bmxgc I~o`h Kgavolo Dolo~xo >:
Hg{gang~ >667.?? Ej~ao`ho H# V~oxjyj O`hozo`j# @w~oj`j J~ao [w{o`xj# [~jg G`iio~ LH hll. Kcj`jkoc Voxbyoz{
Lg{gboxo` O`ol hocoa ~o`ilo javcgag`xo{j [j{xga H^I{ Ko{gajr hj ^[ Eoxaoyoxj# Dolo~xo >665.
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
5/19
7
Ioano~ ?. Km`xmb bo{jc vg`gcjxjo` javcgag`xo{j {ocob {oxw Kcj`jkoc Voxbyoz{w`xwl lo{w{ v`gwam`jo
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
6/19
5
Ioano~ >. Km`xmb o`ocj{j{ bo{jc javcgag`xo{j {ocob {oxw Kcj`jkoc Voxbyoz{
voho xobw` >665 w`xwl lo{w{ v`gwam`jo
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
7/19
9
Xg`xo`i ko~o co`ilob co`ilob vg~bjxw`io` km{x ygjibx# ko{gajr j`hgr# no{g
~oxg~waob {oljx ho` ocmlo{j o`iio~o` hovox hjcjbox hocoa Ioano~ ; ng~jlwx.
Ioano~ ;. Km`xmb vg~bjxw`io` ng~ho{o~lo` hoxo bo{jc javcgag`xo{j Kcj`jkoc
Voxbyoz{ hocoa ag`ko~j ^gcoxjug Ygjibx "km{x ygjibx*# Ko{g Ajr J`hgr ho`
No{g ^oxg.
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
8/19
2
[x~oxgij Vgcol{o`oo` Kcj`jkoc Voxbyoz{
Oio~ xjhol xwavo`i xj hjb {g~xo {j g~ij{ hg`io` lg`zoxoo` hj covo`io`"~waob {oljx*# aolo javcgag`xo{j Kcj`jkoc Voxbyoz{ {gnojl`zo xg~vohw hg`io`
xoxolgcmco ao`odoag` "km~vm~oxg imug~`o`kg* ho` xoxolgcmco lcj`j{ "kcj`jkoc
imug~`o`kg* zo`i xgcob ng~colw {g{woj aj{j ~waob {oljx hocoa njho`i
vgcozo`o`# vg`hjhjlo` ho` vg`gcjxjo`.
Hg`io` xg~njx`zo Vg~oxw~o` Ag`xg~j Lg{gboxo` ^J @mam~
?;82-AG@LG[-VG^-JR->6?6 zo`i hjiw`olo` ohocob j{xjcob [xo`ho~
Vgcozo`o` Lghmlxg~o` "[VL* zo`i xg~hj~j ho~j Vghmao` @o{jm`oc Vgcozo`o`
Lghmlxg~o` "V@VL* ho` [xo`ho~ V~m{ghw~ Mvg~o{jm`oc "[VM*. V@VL hjnwox
mcgb m~io`j{o{j v~meg{j ho` hj{oblo` mcgb Ag`xg~j Lg{gboxo` ^J# {gho`ilo`[VM hjnwox hj xj`ilox ~waob {oljx mcgb v~meg{j aghj{ hg`io` lmm~hj`oxm~
Lmajxg Aghj{ ho` hjxgxovlo` vg`iiw`oo``zo hj ~waob {oljx xg~{gnwx mcgb
vjavj`o` "hj~glxw~*.
[xo`ho~ V~m{ghw~ Mvg~o{jm`oc w`xwl v~meg{j aghj{ hj ~waob {oljx hocoa
ng`xwl Vo`hwo` V~olxjl Lcj`j{?> ! voho wawa`zo hovox hjohmv{j ho~j Vo`hwo`
@o{jm`oc Vgcozo`o` Lghmlxg~o` "V@VL* zo`i xgcob hjnwox mcgb m~io`j{o{j
v~meg{j ao{j`i ao{j`i# xj`iioc hjkmkmllo` ho` hj{g{wojlo` hg`io` lm`hj{j
{o~o`o ho` lmavgxg`{j zo`i oho hj ~waob {oljx. Njco V@VL zo`i xgcob hjnwoxmcgb m~io`j{o{j v~meg{j xg~{gnwx ho` xgcob hj{oblo` mcgb Ag`xg~j Lg{gboxo`
^J {g~xo {g{woj hg`io` lm`hj{j ~waob {oljx aolo xj`iioc hj{gvoloxj mcgb
o`iimxo v~meg{j "[AE* xg~lojx {gnoioj Vo`hwo` V~olxjl Lcj`j{ "VVL* ho`
hj{oblo` vg`iiw`oo``zo hj ~waob {oljx mcgb hj~glxw~ ~waob {oljx xg~{gnwx.
@oaw` njco V@VL xg~{gnwx ngcwa oho oxow xjhol {g{woj hg`io` lm`hj{j
~waob {oljx oxow hocoa V@VL ngcwa ag`ko`xwalo` dg`j{ vg`zoljx zo`i {g{woj
hg`io` lgohoo` gvjhgajmcmij vg`zoljx hj hog~ob-~waob {oljx xg~{gnwx
aolo v~meg{j hj ~waob {oljx xg~{gnwx yodjn aganwox Vo`hwo` V~olxjl Lcj`j{
"VVL* w`xwl ~waob {oljx xg~{gnwx ho` hj{oblo` vg`iiw`oo``zo hj ~waob {oljx
mcgb hj~glxw~ ~waob {oljx. Hocoa ag`zw{w V@VL ho~j m~io`j{o{j v~meg{j
aowvw` VVL w`xwl ~waob {oljx ! v~meg{j aghj{ agang~jlo` vgcozo`o`
lgv~meg{jo``zo {gko~o geglxje "kcj`jkoc geegkxjug`g{{* hocoa boc ag`giollo`
hjoi`m{j{ ho` agang~jlo` xg~ovj ng~ho{o~lo` vg`hgloxo` gujhg`kg!no{gh
aghjkj`g. [gko~o {ghg~bo`o vg~oxw~o` xg~{gnwx hovox hjcjbox {gnoiojao`o
hocoa Ioano~ 8 ng~jlwx.
?> Vg~oxw~o` Ag`xg~j Lg{gboxo` ^J @mam~ ?;82-AG@LG[-VG^-JR->6?6
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
9/19
:
Ioano~ 8. ^j`ilo{o` Vg~oxw~o` Ag`xg~j Lg{gboxo` ^J @mam~
?;82-AG@LG[-VG^-JR->6?6 xg`xo`i [xo`ho~ Vgcozo`o` Lghmlxg~o` V@VL#
[VM ho` VVL.
V~m{g{ {gco`dwx`zo {gxgcob ag`zw{w` Vo`hwo` V~olxjl Lcj j{ "VVL* ^waob[oljx ohocob aganwox Kcj`jkoc Voxbyoz{ {gnoioj {ocob {oxw lmavm`g` ho~j
[j{xga Ko{gajr "J@O KNI* zo`i {oox j j hjvg~iw`olo` w`xwl Doaj o`
Vgagcjbo~oo` Lg{gboxo` "Doalg{ao{* hj ~waob {oljx ! aolo J@O KNI olo`
cgnjb hj{gavw~`olo` hg`io` ag`ibjxw`i H^I ^gcoxjug Ygjibx ho` Ko{gajr
J`hgr {g~xo No{g ^oxg {gxjov vg`igcmavmllo` dg`j{ vg`zoljx ho`
{gco`dwx`zo hovox agano`hj`ilo` "ng`kbao~lj`i* km{x geejkjg`kz o`xo~
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
10/19
?6
~waob {oljx hocoa agang~jlo` cozo`o` lg{gboxo` ng~ho{o~lo` lgohoo`
{gng`o~`zo hjng~jlo` agcocwj Kcj`jkoc Voxbyoz{.
[j{xga Ko{gajr ohocob {woxw ko~o ag`igcmco {wang~ hozo ~waob {oljx
{ggeglxje aw`ilj` hocoa agang~jlo` cozo`o` lg{gboxo` zo`i xg~do`ilow
lgvoho ao{zo~olox ng~ho{o~lo` vg`igcmavmllo` {vglx~wa hjoi`m{j{
vg`zoljx zo`i bmamig` ho` v~m{ghw~ xj holo` zo`i hjng~jlo` ! {gko~o
~j`ilo{`zo xg~hj~j ho~j ; lmavm`g` wxoao zol`j lmhgejlo{j hjoi`m{j{ "JKH
?6* ho` v~m{ghw~ xj`holo` "JKH : KA*# vganjozoo` "km{xj`i* zo`i hovox
ng~wvo xmv!hmy` ovv~mokb# okxjujxz no{gh km{xj`i ho` oxow lmanj`o{j
lghwo`zo# ho` agcocwj Kcj`jkoc Voxbyoz{.?;#?8#?7#?5#?9
J@O!H^I ohocob uo~jo{j {j{xga ko{gajr ug~{j Lgag`xg~jo` Lg{gboxo` ^J
w`xwl J`hm`g{jo zo`i hj{w{w` ng~ho{o~lo` hoxo ho~j ?7 ~waob {oljx ug~xjloc#
agavg~iw`olo` JKH ?6 w`xwl hjoi`m{j{ ho` JKH : KA w`xwl v~m{ghw~
xj`holo` {g~xo njozo ng~ho{o~lo` xo~je zo`i ng~colw voho yolxw xg~{gnwx.
Wvozo xg~{gnwx agao`i ngcwa {gavw~`o ho` ngcwa ag`kg~aj`lo` ~gocjxo{
lgohoo` {gcw~wb vgcm{ml xo`ob oj~ `oaw` {gnoioj xjxjl xm`iiol oyoc# boc
xg~{gnwx ag~wvolo` {woxw lgng~bo{jco` hocoa aganwox {woxw {j{xga
vganjozoo` cozo`o` lg{gboxo` ~waob {oljx ho` w{obo nojl ag`wdw lgvo{xjo`
ho` hovox hjvg~nojlj {g~xo hjxj`iloxlo` lwocjxo{ aowvw` uocjhjxo{ hoxo`zo zo`i ~gv~g{g`xoxje w`xwl J`hm`g{jo. [gnoioj {j{xga zo`i no~w cobj~ J@O!
H^I olo` xg~w{ ng~iwcj~ ho` ng~lgano`i {g{woj xw`xwxo` vg~lgano`io`
cozo`o` lg{gboxo` nojl `o{jm`oc aowvw` ~gijm`oc.?2 Hg`io` ng~olbj~`zo cj{g`{j
i~mwvg~ J@O!H^I xg~bjxw`i xo`iioc ;6 [gvxgang~ >6?6# aolo `oao {jxga
Ko{gajr J@O!H^I ng~wnob ag`dohj J@O!KNI?:.
?; Imchao` C. Km{x!Geegkxjug`g{{ j` o ecox ym~ch Ko` JKH{ bgcv xbg W`jxgh [xoxg{ igx ~bzxba= @G`ic D Agh>667!2?.
?7 Hjo`g ^myco`h H. Aghjkojh Javcjkoxjm`{ em~ xbg bgocxb {oegxz `gx.@ G`ic D Agh >667< ;7;"?8*4?8;:!8?.
?5 I~goccz K. Oexg~ ?> zgo~{ me Ko{gajr j` J~gco`h# o aodm~ ~gujgy cgohj`i xm jx{ amhg~ j{oxjm` o`h
grvo`{jm` o{ o kg`x~oc vjcco~ j` bm{vjxoc ew`hj`i vmcjkz. J~gco`h Hgvo~xag`x me Bgocxb# >668.?9 Ko{gajr W`jx Hgvo~xag`x me Bgocxb o`h Kbjch~g . Ko{gajr Ago{w~gag x j` J~j{b Bm{vjxoc{. J~gco h
Hgvo~xag`x me Bgocxb# >667.?2 Ej~ao`ho H. O`ocj{j{ Vganozo~o` lgvoho Vgang~j Cozo`o` Lg{gboxo` "VVL* ag`iiw`olo` J@O!KNI
ag`hgloxj bo~ovo` {gawo vjbol {g{woj Kcj`jkoc Voxbyoz{. Hj{oavojlo` voho Ym~l{bmv Javcgag`xo{jJ@O!KNI Vg~kgvoxo` X~o`{em~ao{j hj ^waob [oljx Hog~ob "^[H* hj{gcg`iio~olo` mcgb O{m{jo{j
^waob [oljx Hog~ob [gcw~wb J`hm`g{jo "O^[OHO* Doyo No~ox hj Bmxgc O{xm` X~mvjko`o No`hw`i# >;
Dw`j >6??.?: [w~ox Gho~o` Hj~glxw~ Dg`hg~oc Nj`o Vgcozo`o` Aghjl Lgag`xg~jo` Lg{gboxo` ^J @mam~ J^.6;.6?-
J-7969?6 Xo`iioc ?2 Mlxmng~ >6?6.
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
11/19
??
V>DL Lgag`xg~jo` Lg{gboxo` ^J xgcob ag`ioholo` vg~xgawo` hg`io`
{gcw~wb vg~bjavw`o` v~meg{j ho` lmcgijwa hj Hg`vo{o~ Nocj voho xo`iioc >;@mugang~ >66: ho` ag`ibo{jclo` lgvwxw{o` {gnoioj ng~jlwx4
?. Lg{gvoloxo` ho` lmajxag` ng~{oao {gcw~wb vg~bjavw`o` v~meg{j ho`
Lmcgijwa {gxjov vg~bjavw`o` v~meg{j aganwox ?6 vg`zoljx xg~no`zol
[xo`ho~-Vghmao` Vgcozo`o` Aghj{ "[-VVA* ho` Kcj jkoc Voxbyoz{
w`xwl agcg`ilovj J@O!H^I hocoa V~mi~oa Doaj`o` Lg{gboxo`.
>. Vg~xgawo` {gco`dwx`zo xo`iioc >> Do`wo~j >6?6 hj{gcg`iio~olo` mcgb
Vw{ox Vganjozoo` ho` Doaj`o` Lg{gboxo` "V>DL* [gl~gxo~jox Dg`hg~oc
Hgvlg{ ^J aganobo{ {gcw~wb [VA ho` KV.
^g`ko`o vg~xgawo` co`dwxo` xo`iioc >> Do`wo~j >6?6 hjw`hw~ ho` xg~gocj{o{j
voho xo`iioc 9!: Ov~jc >6?6 hj Noxoa hg`io` vganobo{o` lganocj ag`ig`oj
[xo`ho~ Vgcozo`o` Lghmlxg~o` {gxjov vg~bjavw`o` v~meg{j. @oaw` {gxgcob
jxw xjhol oho xj`hol co`dwx {gxg~w{`zo.
Xg~cgvo{ ho~j lg`hoco vg`iiw`oo` Kcj`jkoc Voxbyoz{ {gnoioj vgcg`ilov J@O!
KNI< javcgag`xo{j Kcj`jkoc Voxbyoz{ {o`iox ng~ao`eoox noij v~meg{j hocoa
agang~jlo` vgcozo`o`# vg`hjhjlo` aowvw` vg`gcjxjo` hj ~waob {oljx{gnoiojao`o hovox hjcjbox hocoa ioano~ 7 {oavoj 9 ng~jlwx.
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
12/19
?>
Ioano~ 7. Javcgag`xo{j Kcj`jkoc Voxbyoz{ hocoa njho`i vgcozo`o` hj ~waob
{oljx.
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
13/19
?;
Ioano~ 5. Javcgag`xo{j Kcj`jkoc Voxbyoz{w`xwl vg`gcjxjo` hj ~waob {oljx.
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
14/19
?8
Ioano~ 9. Javcgag`xo{j Kcj`jkoc Voxbyoz{ hjlojxo` hg`io` o{g{ag` vg`jcojo`
w`xwl vg{g~xo hjhjl aobo{j{yo ho` vg{g~xo v~mi~oa hmlxg~ {vg{jocj{ hj
~waob {oljx aowvw` ~waob {oljx dgdo~j`i vg`hjhjlo`.
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
15/19
?7
Lm`{gv. lm`{x~wl{j aowvw` amhgc javcgag`xo{j Kcj`jkoc Voxbyoz{{gko~o xjhol
co`i{w`i {gnoiojao`o hjwxo~olo` hjoxo{ nobyo4
Kcj jkoc Voxbyoz{ {gnoioj j`{x~wag` vgcozo`o` ng~emlw{ lgvoho vo{jg`
"voxjg`x!emkw{gh ko~g*# xg~j`xgi~o{j# ng~lg{j`oanw`io` ho~j vo{jg` ao{wl
hj~oyox {oavoj vwco`i {ganwb "km`xj`wmw{ ko~g*# dgco{ olo` hmlxg~-vg~oyox
vg`o`iiw`i doyon vo{jg` "hwxz me ko~g*# wxjcjxo{ vgag~jl{oo` vg`w do`i#vg`iiw`oo` mnox mnoxo` xg~ao{wl o`xjnjmxjlo# v~m{ghw~ xj`holo` mvg~o{j#
o`xj{jvo{j lgaw`ilj`o` xg~dohj`zo aghjkoc g~~m~{ "coxg` ho` olxje# `zo~j{
xg~dohj aowvw` lgdohjo` xjhol hjbo~ovlo`-LXH* ho` vg`kgiobo` lgaw`ilj`o`
kghg~o "bo~a{* {g~xo j`egl{j `m{mlmajoc hocoa ~o`ilo lg{gcoaoxo` vo{jg`
"voxjg`x {oegxz*# ag`hgxgl{j hj`j xjxjl xjxjl vmxg`{joc ng~j{jlm {gcoao v~m{g{cozo`o` vg~oyoxo` vo{jg` "x~okg~{ agxbmhmcmiz* hocoa ~o`ilo ao`odgag`
~j{jlm "~j{l{ ao`oigag`x*# ~g`ko`o vgawco`io` vo{jg` "voxjg`x hj{kbo~ig* #wvozo vg`j`iloxo` awxw cozo`o` ng~lg{j`oanw`io` "km`xj`wmw{ qwocjxzjav~mugag`x* nojl hg`io` vg`hgloxo` xgb`jl XMK "Xbgm~z me Km`{x~oj`x{*
w`xwl {j{xga aowvw` j`hjujhw v~meg{j# vg`wcw{w~o` lj`g~do "vg~em~ao`kg*
j`hjujhw v~meg{j aowvw` lgcmavml "xgoa!ym~l*.
Ag~wvolo` {woxw ~o`ilojo` {j{xga zo`i hovox hjvg~iw`olo` {gnoioj
j`{x~wag` w`xwl agag`wbj vg~{zo~oxo` vg jcojo` Ol~ghjxo{j ho~j LmajxgOl~ghjxo{j ^waob [oljx "LO^[* ug~{j no~w aowvw` ho~j Dmj`x Kmaaj{{jm`
J`xg~`oxjm`oc em~ Bm{vjxoc "DKJ* ug~{j >6?? w`xwl {xo`ho~ {xo`ho~ hocoa
[gkxjm` J. Voxjg`x Kg`xg~gh [xo`ho~h aowvw` hocoa [gkxjm` JJ. Bgocxbko~g
M~io`jtoxjm` Ao`oigag`x [xo`ho~h {gnoiojao`o jcw{x~o{j Ioano~ 2 {oavoj
?6 ng~jlwx.
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
16/19
?5
Ioano~ 2. Kcj`jkoc Voxbyoz{ho` DKJ >6?? Okk~ghjxoxjm` [xo`ho~h{
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
17/19
?9
Ioano~ :. [j{xgaoxjlo hocoa DKJ >6?? Bm{vjxoc [xo`ho~h{ ho` Vg`jcojo``zo
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
18/19
?2
Ioano~ ?6. Kcj`jkoc Voxbyoz{ ho` xgb`jl X~okg~ Agxbmhmcmiz zo`i hjiw`olo`
mcgb {w~ugzm~ hocoa ~o`ilo Ol~ghjxo{j DKJ >6??
8/3/2019 Dody Firmanda 2011 - Peran Clinical Pathways dalam Efisiensi, Efektifitas dan Ekuiti
19/19
?:
Lg{javwco`4
Ho~j w~ojo` {j`ilox hjoxo{ hg`io` bo`zo {gcgano~ Kcj`jkoc Voxbyoz{ !ag~wvolo` {woxw j`{x~wag` zo`i lmav~gbg`{je ag~o`ilwa {gko~o xg~vohw
njho`i vgcozo`o`# vg`hjhjlo` ho` vg`gcjxjo` aowvw ol~ghjxo{j {g~xo njco
hjxj dow ho~j {gij glm`maj lg{gboxo` hovox agcol{o`olo` gej{jg`{j
vganjozoo` hg`io` agao`eooxlo` {gmvxjaoc aw`ilj` bo~j ~oyox vo{jg`#
ag`igcjaj o{j vgag~jl{oo` vg`w`do`i-conm~oxm~jwa-xj holo` zo`i xjhol
hjvg~cwlo`# ag`iiw`olo` mnox mnoxoo` "xg~wxoao o`xjnjmxjl* {g{woj gujhg`kg!
no{gh668 w`xwl
njho`i lg{gboxo` xg~ywdwh "{gko~o aok~m!{z{xga*.
Xg~jao lo{jb# {gamio ng~ao`eoox.Dolo~xo >? @mugang~ >6??
Hmhz Ej~ao`ho
Lgxwo Lmajxg Aghjl
^[WV Eoxaoyoxj Dolo~xo.
bxxv4--yyy.{k~jnh.kma-Lmajxg'>6Aghjl
Top Related